Happenings

Edward J. Poziomek, former director of research, U.S. Army Chemical Research at the Development and Engineering Center at Aberdeen Proving Ground, Md., became Sigma Xi’s new executive director on December 1. Poziomek joined the society in 1961 and has served on the board of directors since 1976. His areas of research include surface chemistry, spectroscopy, physical-organic chemistry and organic synthesis. Charles E. Hammer Jr., associate vice president for health affairs and professor


Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Edward J. Poziomek, former director of research, U.S. Army Chemical Research at the Development and Engineering Center at Aberdeen Proving Ground, Md., became Sigma Xi’s new executive director on December 1. Poziomek joined the society in 1961 and has served on the board of directors since 1976. His areas of research include surface chemistry, spectroscopy, physical-organic chemistry and organic synthesis.

Charles E. Hammer Jr., associate vice president for health affairs and professor of obstetrics and gynecology at the University of Virginia Medical Center, will become president of the North Carolina Biotechnology Center on February 1, 1988. Hammer will replace Richard J. Patterson, who resigned in December 1986. Roy E. Morse, retired vice president for research and development at R.J. Reynolds Industries, Inc., is interim president. The Biotechnology Center is a non-profit corporation funded by the N.C. General Assembly.

The Boyce Thompson Institute for Plant Research named Richard C. Staples the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio